The 2021 Biosimilar Medicines Virtual Summit will explore the latest developments in biosimilar medicines policies and look at future opportunities and challenges in this field. In a novel online format, each live session will be complemented by resources such as recorded interviews and presentations, infographics and reports. Registration for this summit will be free and will grant access to a website containing all the related material.

Today the European #StructuredDialogue with MS, the @EU_Commission and relevant meds supply chain stakeholders is taking place.
📰Read our Press release for more

COVID19 taught us that EU collaboration can reduce the risk of medicine shortages with:

⛓️Optimization of the procurement process & long term market solutions
📈More investments in manufacturing technology
🖥️Digital transformation of the regulatory system

If you have:
➡️Project management skills
➡️Knowledge of marketing authorisation regulatory processes
➡️Knowledge of Telematics and/or digital health

You can apply as a Regulatory Officer at Medicines for Europe by 9 July 📅

The EU #StructuredDialogue can lead us to supply chain #resilience & #EquitableAccess for patients through:

📈Optimization of procurement process & long-term market solutions
💊Investments in medicines manufacturing
📃Improvement of regulatory efficiency

Load More...